InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-08-09 00:00:00 ET · period of report 2024-08-07 · accession 0001601830-24-000122 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-08-09 2024-08-07+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +50.0K 778.7K +7% $0
DM 2024-08-09 2024-08-07+ RXRX Gibson Christopher CEO, Dir S - Sale $6.86 -50.0K 758.7K -6% -$343.0K
DM 2024-08-09 2024-08-07+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -50.0K 6.20M -0.8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-08-07 C A 30,000 $0.00 788,738 D — —
2 Common Class A Common Stock 2024-08-08 C A 20,000 $0.00 778,738 D — —
3 Common Class A Common Stock 2024-08-08 S D 20,000 $6.50 758,738 D — —
4 Common Class A Common Stock 2024-08-07 S D 30,000 $7.10 758,738 D — —
5 Derivative Class B Common Stock 2024-08-08 C D 20,000 $0.00 6,176,700 D $0.00 · — to — 20,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
6 Derivative Class B Common Stock 2024-08-07 C D 30,000 $0.00 6,196,700 D $0.00 · — to — 30,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.